179 related articles for article (PubMed ID: 34286514)
101. Atractylenolide III predisposes miR-195-5p/FGFR1 signaling axis to exert tumor-suppressive functions in liver cancer.
Sheng L; Li J; Li N; Gong L; Liu L; Zhang Q; Li X; Luo H; Chen Z
J Food Biochem; 2021 May; 45(5):e13582. PubMed ID: 33768570
[TBL] [Abstract][Full Text] [Related]
102. CircSCMH1 Accelerates Sorafenib Resistance in Hepatocellular Carcinoma by Regulating HN1 Expression via miR-485-5p.
Li M; Pang X; Xu H; Xiao L
Mol Biotechnol; 2024 Feb; ():. PubMed ID: 38372878
[TBL] [Abstract][Full Text] [Related]
103. Long noncoding RNA DLEU2 promotes growth and invasion of hepatocellular carcinoma by regulating miR-30a-5p/PTP4A1 axis.
Fu Y; Li B; Huang R; Ji X; Bai WK
Pathol Res Pract; 2022 Oct; 238():154078. PubMed ID: 36049439
[TBL] [Abstract][Full Text] [Related]
104. LINC02362/hsa-miR-18a-5p/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma.
Quan B; Liu W; Yao F; Li M; Tang B; Li J; Ren Z; Yin X
Am J Cancer Res; 2023; 13(11):5590-5609. PubMed ID: 38058825
[TBL] [Abstract][Full Text] [Related]
105. MiR-371a-5p Positively Associates with Hepatocellular Carcinoma Malignancy but Sensitizes Cancer Cells to Oxaliplatin by Suppressing BECN1-Dependent Autophagy.
Lv Z; Qiu X; Jin P; Li Z; Zhang Y; Lv L; Song F
Life (Basel); 2022 Oct; 12(10):. PubMed ID: 36295086
[TBL] [Abstract][Full Text] [Related]
106. Role of lncSLCO1C1 in gastric cancer progression and resistance to oxaliplatin therapy.
Xiao YF; Li BS; Liu JJ; Wang SM; Liu J; Yang H; Hu YY; Gong CL; Li JL; Yang SM
Clin Transl Med; 2022 Apr; 12(4):e691. PubMed ID: 35474446
[TBL] [Abstract][Full Text] [Related]
107. Antitumor Activity of lncRNA NBAT-1 via Inhibition of miR-4504 to Target to WWC3 in Oxaliplatin-Resistant Colorectal Carcinoma.
Li C; Li X
J Healthc Eng; 2022; 2022():9121554. PubMed ID: 35494512
[TBL] [Abstract][Full Text] [Related]
108. Polysaccharides Produced by the Mushroom
Gou Y; Zheng X; Li W; Deng H; Qin S
Integr Cancer Ther; 2022; 21():15347354221090221. PubMed ID: 35426328
[TBL] [Abstract][Full Text] [Related]
109. circ_HMGCS1 modulates hepatocellular carcinoma chemoresistance via miR-338-5p/IL-7 pathway.
Zhang S; Ma J; Yu T; Song Z; Lau WY; Zha Y
J Cell Mol Med; 2024 Mar; 28(6):e18137. PubMed ID: 38445791
[TBL] [Abstract][Full Text] [Related]
110. Role of UPF1 in lncRNA-HEIH regulation for hepatocellular carcinoma therapy.
Cha H; Kim M; Ahn N; Jeong SD; Ignatova E; Chi SW; Kim HH; Hwang J
Exp Mol Med; 2024 Feb; 56(2):344-354. PubMed ID: 38297160
[TBL] [Abstract][Full Text] [Related]
111. Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment.
Zhang F; Hu K; Liu W; Quan B; Li M; Lu S; Chen R; Ren Z; Yin X
Cell Mol Gastroenterol Hepatol; 2023; 15(3):573-591. PubMed ID: 36513250
[TBL] [Abstract][Full Text] [Related]
112. The HN1/HMGB1 axis promotes the proliferation and metastasis of hepatocellular carcinoma and attenuates the chemosensitivity to oxaliplatin.
Wang R; Fu Y; Yao M; Cui X; Zhao Y; Lu X; Li Y; Lin Y; He S
FEBS J; 2022 Oct; 289(20):6400-6419. PubMed ID: 35596723
[TBL] [Abstract][Full Text] [Related]
113. Transcription factor B-MYB activates lncRNA CCAT1 and upregulates SOCS3 to promote chemoresistance in colorectal cancer.
Liu F; Wang Y; Cao Y; Wu Z; Ma D; Cai J; Sha J; Chen Q
Chem Biol Interact; 2023 Apr; 374():110412. PubMed ID: 36812959
[TBL] [Abstract][Full Text] [Related]
114. LncRNA NEAT1 modulates sorafenib resistance in hepatocellular carcinoma through regulating the miR-149-5p/AKT1 axis.
Niu Y; Tang G; Wu X; Wu C
Saudi J Gastroenterol; 2020 May; 26(4):194-203. PubMed ID: 32461380
[TBL] [Abstract][Full Text] [Related]
115. The Role of microRNAs in Regulating Cancer Cell Response to Oxaliplatin-Containing Regimens.
Tavakoli Pirzaman A; Ebrahimzadeh Pirshahid M; Babajani B; Rahmati A; Niknezhad S; Hosseinzadeh R; Taheri M; Ebrahimi-Zadeh F; Doostmohamadian S; Kazemi S
Technol Cancer Res Treat; 2023; 22():15330338231206003. PubMed ID: 37849311
[TBL] [Abstract][Full Text] [Related]
116. Identification of regulatory mRNA and microRNA for differentiation into cementoblasts and periodontal ligament cells.
Iwata T; Mizuno N; Nagahara T; Kaneda-Ikeda E; Kajiya M; Kitagawa M; Takeda K; Yoshioka M; Yagi R; Takata T; Kurihara H
J Periodontal Res; 2021 Jan; 56(1):69-82. PubMed ID: 32797637
[TBL] [Abstract][Full Text] [Related]
117. HGF-mediated elevation of ETV1 facilitates hepatocellular carcinoma metastasis through upregulating PTK2 and c-MET.
Zhang T; Wang Y; Xie M; Ji X; Luo X; Chen X; Zhang B; Liu D; Feng Y; Sun M; Huang W; Xia L
J Exp Clin Cancer Res; 2022 Sep; 41(1):275. PubMed ID: 36109787
[TBL] [Abstract][Full Text] [Related]
118. Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axis.
Zheng Z; Wu M; Li H; Xu W; Yang M; Pan K; Ni Y; Jiang T; Zheng H; Jin X; Zhang Y; Ding L; Fu J
BMC Med; 2023 Apr; 21(1):132. PubMed ID: 37013584
[TBL] [Abstract][Full Text] [Related]
119. LINC01234/MicroRNA-31-5p/MAGEA3 Axis Mediates the Proliferation and Chemoresistance of Hepatocellular Carcinoma Cells.
Chen Y; Zhao H; Li H; Feng X; Tang H; Qiu C; Zhang J; Fu B
Mol Ther Nucleic Acids; 2020 Mar; 19():168-178. PubMed ID: 31838274
[TBL] [Abstract][Full Text] [Related]
120. Overexpression of the lncRNA HOTAIRM1 promotes lenvatinib resistance by downregulating miR-34a and activating autophagy in hepatocellular carcinoma.
Gu D; Tong M; Wang J; Zhang B; Liu J; Song G; Zhu B
Discov Oncol; 2023 May; 14(1):66. PubMed ID: 37171645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
